 | | | | Patient groups are spending millions of dollars on television and local advertisements targeting U.S. Sunday morning political talk shows. | | | | | | Hong Kong health authorities reported 32,430 new COVID-19 cases on Sunday, as the city's leader said her government was trying build capacity to deal with the crisis that has swept through care homes. | | | | | | Mainland China reported 1,807 new local symptomatic COVID-19 cases on Sunday, the highest daily figure in two years and more than triple the caseload of the previous day, as surging infections in a northeastern province squeeze health resources. | | | | | | France is to start offering a fourth COVID-19 vaccination shot to people over 80 years old who had their previous booster dose more than three months ago, French Prime Minister Jean Castex told daily Le Parisien in an interview published on Saturday. | | | | | | China has granted approval to five COVID-19 antigen kits made by local companies to be used for self-testing, state broadcaster CCTV said on Saturday, as it tweaks its testing regime that has been pressured by Omicron. | | | | | | Hong Kong reported 27,647 new COVID-19 cases on Saturday, with city leader Carrie Lam saying the outbreak was not yet past its peak despite recent daily case numbers slightly levelling off. | | | | | | Australia's Prime Minister Scott Morrison said the nation's political leaders want to move to a new phase of living with COVID-19 as though it were the flu, but would consult health experts. | | | | | | Mainland China reported more than 1,500 new local COVID-19 infections on Saturday, the most since the first nationwide outbreak in early 2020, as the Omicron variant prompted Beijing to introduce self-testing kits for the first time. | | | | | | South Korea reported a new record daily high of 383,665 COVID-19 cases, the Korea Disease Control and Prevention Agency said on Saturday, amid a surge of Omicron infections. | | | | | | British drugmaker AstraZeneca Plc said the U.S. Food and Drug Administration approved its cancer drug, jointly developed with U.S.-based Merck & Co , as a treatment for patients with early-stage breast cancer with certain mutations. | | | | | |
